What's breaking now, across thousands of outlets.
Sensible Biotechnologies is looking to mark its territory in the increasingly hot space of mRNA therapeutics, raising $47 million in a Series A round to develop its manufacturing approach. “Current mRNA technology is fine for ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Epicrispr Biotechnologies continued to show encouraging findings from testing of its epigenetic editing treatment for the genetic muscle disease facioscapulohumeral muscular dystrophy.
These lesser-known indoor air quality factors affect your health every day, even when your home looks and smells perfectly clean
Decisions by health insurers to trim the size of their geographic footprints is a way to boost bottom lines as reimbursement flattens and cost of care increases.
Researchers found having better cardiorespiratory fitness as a child and teenager could reduce risk of depression as an adult.
Composition of matter provides U.S. protection through Sept. 6, 2044, as forazapadin advances in Phase 2 development TORONTO, Oct. 05, 2026 (GLOBE NEWSWIRE) — Satellos Bioscience Inc.
Partnership intended to establish a Texas-based manufacturing pathway for pharmaceutical-grade ibogaine as TIRC advances its planned U.S.
